Acrivon Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $32k | 16k | 2.03 |
| 2024-12-31 | $619k | 103k | 6.02 |
| 2024-09-30 | $555k | 79k | 7.00 |
| 2024-03-31 | $908k | 127k | 7.15 |
| 2023-09-30 | $1.0M | 105k | 9.56 |
| 2023-06-30 | $1.3M | 100k | 12.96 |